EUVIMEDEUVIMED entdecken
Vergleichsstudie

Therapeutic Effectiveness of Atresiaplasty Compared to Osseointegrated Bone Conduction Devices

Evan J Patel iD, Michelle Louie, Sabina Yungert, Raquel Mendoza, Jihyun Stephans, Dylan K Chan iD

The Laryngoscope · 2026

DOI: 10.1002/lary.70021 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift The Laryngoscope, 2026. Verfasst von Evan J Patel und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head & Neck Surgery, University of California San Francisco, San Francisco, California, USA. Hauptthemen laut MEDLINE: Bone Conduction, Ear, Hearing Aids, Congenital Abnormalities. Die Arbeit nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To compare total access to sound in congenital aural atresia patients who underwent atresiaplasty or placement of an osseointegrated bone conduction device (OBCD).

Methods

We conducted a retrospective cohort study at a single tertiary academic center of all pediatric patients with congenital aural atresia. The primary aim was to compare the therapeutic effectiveness of atresiaplasty and OBCD. Mean disease alleviation (MDA) of the air conduction pure tone average (AC PTA) was calculated based on post‐operative change in air conduction thresholds with weighting of the hearing benefit based on device usage in the OBCD cohort.

Results

169 pediatric patients (56.2% male, 83.4% complete) with congenital aural atresia were identified. 45 ears treated with atresiaplasty and 38 ears implanted with an OBCD were found to have complete pre‐ and post‐operative audiometric data and were included in the analysis. The improvement in AC PTA after OBCD was higher compared to atresiaplasty (59.6% vs. 37.1%, p < 0.001). However, MDA of AC PTA was greater in the atresiaplasty cohort compared to OBCD (37.1% vs. 23.0%, p = 0.001). Multivariable regression accounting for clinical and sociodemographic co‐variates demonstrated a higher MDA for atresiaplasty compared to OBCD ( p = 0.01).

Conclusions

Select patients with congenital aural atresia may obtain improved total access to sound, or auditory dosage, from an atresiaplasty in the hands of an experienced surgeon compared to an OBCD due to the fact that a canal reconstruction provides the same access to sound throughout the day while external device utilization can be variable. Level of Evidence: Level 3.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bone ConductionEarHearing AidsCongenital AbnormalitiesHearing Loss, ConductiveHumansMaleRetrospective StudiesFemaleTreatment OutcomeChildChild, PreschoolOsseointegrationInfantAdolescentAudiometry, Pure-Tone

Stichwörter der Autor:innen

atresiaplastyaural atresiaosseointegrated bone conduction device

Autor:innen und Institutionen

  • Department of Otolaryngology-Head & Neck Surgery, University of California San Francisco, San Francisco, California, USA.
  • Department of Audiology, University of California San Francisco Benioff Children's Hospital, Oakland, California, USA.
  • Department of Audiology, University of California San Francisco Benioff Children's Hospital, San Francisco, California, USA.

ORCID-Profile: Evan J Patel, Dylan K Chan

Zitieren

APA

Patel, E. J., Louie, M., Yungert, S., Mendoza, R., Stephans, J., & Chan, D. K. (2026). Therapeutic Effectiveness of Atresiaplasty Compared to Osseointegrated Bone Conduction Devices. The Laryngoscope. https://doi.org/10.1002/lary.70021

Vancouver

Patel EJ, Louie M, Yungert S, Mendoza R, Stephans J, Chan DK. Therapeutic Effectiveness of Atresiaplasty Compared to Osseointegrated Bone Conduction Devices. The Laryngoscope. 2026. doi:10.1002/lary.70021

BibTeX
@article{Patel2026,
  author = {Patel, Evan J and Louie, Michelle and Yungert, Sabina and Mendoza, Raquel and Stephans, Jihyun and Chan, Dylan K},
  title = {Therapeutic Effectiveness of Atresiaplasty Compared to Osseointegrated Bone Conduction Devices},
  journal = {The Laryngoscope},
  year = {2026},
  doi = {10.1002/lary.70021}
}
Kostenlos starten →